Skip to main content
Clinical Trials/NCT01503151
NCT01503151
Completed
Phase 2

Cognitive Biases Modification Treatment for Social Anxiety

Tel Aviv University1 site in 1 country95 target enrollmentJanuary 2012
ConditionsSocial Phobia

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Social Phobia
Sponsor
Tel Aviv University
Enrollment
95
Locations
1
Primary Endpoint
Social Anxiety Scale (LSAS) - diagnostic interview
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

Adults with Social Phobia will be randomly assigned to either an attention bias modification treatment, interpretation bias modification treatment, both, or a placebo control condition not designed to change cognitive bias patterns.

Outcome measures will be social anxiety symptoms and severity as measured by gold standard questionnaires as well as diagnosis of social phobia disorder and symptom counts derived from structured clinical interviews based on DSM-IV criteria.

The investigators expect to find significant reduction in social anxiety symptoms in the Treatment groups relative to the placebo control group. The investigators want to find out the relative efficacy of attention and interpretation oriented treatments and the combination of the two.

Registry
clinicaltrials.gov
Start Date
January 2012
End Date
March 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Factorial
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Yair Bar-Haim

Study Principal Investigator

Tel Aviv University

Eligibility Criteria

Inclusion Criteria

  • People suffering from social anxiety

Exclusion Criteria

  • Pharmacological or Psychological treatment

Outcomes

Primary Outcomes

Social Anxiety Scale (LSAS) - diagnostic interview

Time Frame: Expected time frame of 6 weeks per participant. Participants will be assessed before and after the administration of the training/control protocols

LSAS is a 24-items clinician-administered scale developed for the assessment of fear and avoidance associated with social. The LSAS assesses a wide range of both social interaction and performance/observation situations, which are rated for degree of fear/anxiety and frequency of avoidance.

Secondary Outcomes

  • The Mini International Neuropsychiatric Interview (MINI).(expected time frame of 6 weeks per participant. Participants will be assessed before and after the administration of the training/control protocols)

Study Sites (1)

Loading locations...

Similar Trials